[1]
NA McBee, DF Hanley, CS Kase, K Lane, and JR Carhuapoma, “The importance of an independent oversight committee to preserve treatment fidelity, ensure protocol compliance, and adjudicate safety endpoints in the ATACH II trial”, JVIN , vol. 5, no. 1.5, Nov. 2023.